Literature DB >> 8307131

Snoring, sympathetic activity and cardiovascular risk factors in a 70 year old population.

P Jennum1, K Schultz-Larsen, N Christensen.   

Abstract

In order to describe the relation between snoring, cardiovascular risk factors, metabolic factors and sympathetitic activity, 804 70-year-old males and females were classified according to snoring habits and life-style factors (alcohol and tobacco consumption), blood pressure, body mass index (BMI), plasma lipids (triglycerides, cholesterol, high density lipoprotein), plasma catecholamines (epinephrine, norepinephrine), fasting blood glucose and glucose tolerance test (1 gram glucose per kg body weight given and blood glucose was measured 1 and 2 hours thereafter) were evaluated in all participants. Self-reported snoring was associated with gender (males showed higher prevalence than females, p < 0.05), alcohol consumption (p < 0.01), BMI (p < 0.001), systolic (p < 0.01) and diastolic (p < 0.05) blood pressure, glucose tolerance test (p < 0.01), plasma norepinephrine (p < 0.05) and partly with tobacco consumption (p = 0.08). No associations were found between snoring and fasting glucose, plasma lipids, plasma epinephrine or in the use of antihypertensive medication. In multivariate analysis, with forced entry of gender, BMI, physical activity, alcohol and tobacco consumption, the relation between snoring and blood pressure ceased; only systolic blood pressure was associated with snoring (p < 0.05). Snoring was still associated with plasma norepinephrine (p < 0.001) and abnormal glucose tolerance (p < 0.001). We conclude that, in a 70-year-old population, snoring is associated with gender, BMI and alcohol consumption. Snores showed higher plasma norepinephrine and abnormal glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307131     DOI: 10.1007/BF00209524

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  24 in total

1.  A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.

Authors:  G A ROSE; W W HOLLAND; E A CROWLEY
Journal:  Lancet       Date:  1964-02-08       Impact factor: 79.321

2.  Snoring every night as a risk factor for myocardial infarction: a case-control study.

Authors:  R D'Alessandro; C Magelli; G Gamberini; S Bacchelli; E Cristina; B Magnani; E Lugaresi
Journal:  BMJ       Date:  1990-06-16

3.  Obstructive apnea: sympathetic activity, respiration and sleep, a case report.

Authors:  M V Vitiello; E C Giblin; R B Schoene; J B Halter; P N Prinz
Journal:  Neurobiol Aging       Date:  1982       Impact factor: 4.673

4.  Secular trends in serum cholesterol, high density lipoproteins and triglycerides 1964-1987.

Authors:  A Sjøl; K Grunnet; M Schroll
Journal:  Int J Epidemiol       Date:  1991-03       Impact factor: 7.196

Review 5.  Is snoring a cause of vascular disease? An epidemiological review.

Authors:  P C Waller; R S Bhopal
Journal:  Lancet       Date:  1989-01-21       Impact factor: 79.321

6.  Comparison of self- and spouse reports of snoring and other symptoms associated with sleep apnea syndrome.

Authors:  C L Wiggins; W W Schmidt-Nowara; D B Coultas; J M Samet
Journal:  Sleep       Date:  1990-06       Impact factor: 5.849

7.  Snoring and systemic hypertension--an epidemiological study.

Authors:  T Gislason; H Aberg; A Taube
Journal:  Acta Med Scand       Date:  1987

8.  Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men.

Authors:  T Gislason; M Almqvist
Journal:  Acta Med Scand       Date:  1987

9.  Snoring as a risk factor for hypertension and angina pectoris.

Authors:  M Koskenvuo; J Kaprio; M Partinen; H Langinvainio; S Sarna; K Heikkilä
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

10.  Prevalence of every night snoring and obstructive sleep apnoeas among 30-69-year-old men in Bologna, Italy.

Authors:  F Cirignotta; R D'Alessandro; M Partinen; M Zucconi; E Cristina; R Gerardi; F M Cacciatore; E Lugaresi
Journal:  Acta Neurol Scand       Date:  1989-05       Impact factor: 3.209

View more
  9 in total

1.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

2.  Sleep and Glucose Intolerance/Diabetes Mellitus.

Authors:  Mary Ip; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2007

3.  Snoring and atherosclerotic manifestations in a 70-year-old population.

Authors:  P Jennum; K Schultz-Larsen; N J Christensen
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

4.  The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea.

Authors:  Hesham A Hassaballa; Aiman Tulaimat; James J Herdegen; Babak Mokhlesi
Journal:  Sleep Breath       Date:  2005-12       Impact factor: 2.816

5.  Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population.

Authors:  C Meisinger; M Heier; H Loewel
Journal:  Diabetologia       Date:  2005-01-11       Impact factor: 10.122

6.  Sleep and metabolism: an overview.

Authors:  Sunil Sharma; Mani Kavuru
Journal:  Int J Endocrinol       Date:  2010-08-02       Impact factor: 3.257

7.  Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective.

Authors:  Won Lee; Swamy Nagubadi; Meir H Kryger; Babak Mokhlesi
Journal:  Expert Rev Respir Med       Date:  2008-06-01       Impact factor: 3.772

8.  Snoring, daytime sleepiness, and incident cardiovascular disease in the health, aging, and body composition study.

Authors:  Yohannes Endeshaw; Thomas B Rice; Ann V Schwartz; Katie L Stone; Todd M Manini; Suzanne Satterfield; Steven Cummings; Tamara Harris; Marco Pahor
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

9.  Evaluating changes in pulse transit time drop index in patients with obstructive sleep apnea before and during CPAP therapy.

Authors:  Elham Kalantari; Forough Kalantari; Maryam Edalatifard; Besharat Rahimi
Journal:  Clin Respir J       Date:  2022-08-08       Impact factor: 1.761

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.